Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

for
Neuroendocrine Tumors, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07151391

Phase 2, Recruiting

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Brunswick NJ, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07128303

Phase 1, Recruiting

SLV-324 Treatment of Metastatic Solid Tumors

for
Metastatic Solid Tumors
Location: Philadelphia PA, Cleveland OH, St Louis MO, Houston TX,
Sponsor: Solve Therapeutics

Sex: All

Age: 18+

Code: NCT07108114

Phase 1, Recruiting

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT07365007

Recruiting

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

for
IDH1-Mutated Malignancies
Location: Atlanta GA, Houston TX
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT07006688

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase 1, Recruiting

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

for
Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer,
Location: Boston MA, New Haven CT, Sarasota FL, Houston TX,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT07578571

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, New Orleans LA, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

for
Advanced Malignant Solid Neoplasm, Malignant Brain Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 39

Code: NCT07174661

Recruiting

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

for
Refractory Solid Tumor, Hepatocellular Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT05468359

Phase 1, Phase 2, Recruiting

Prevent Cancer- Greenville

for
Cancer, High-Risk Cancer
Location: Greenville SC
Sponsor: Prisma Health-Upstate

Sex: All

Age: 18+

Code: NCT04947098

Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

for
HER2-Positive Solid Tumor
Location: Nashville TN
Sponsor: Yuhan Corporation

Sex: All

Age: 18+

Code: NCT05523947

Phase 1, Phase 2, Recruiting

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Charleston SC, Augusta GA, Greenville SC, Anderson SC,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06279013

Recruiting

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05904782

Recruiting

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

for
Malignant Female Reproductive System Neoplasm
Location: Decatur GA, Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT06709534

Recruiting

A Study of JNJ-1761981 in Participants With Solid Tumors

for
Neoplasms
Location: The Bronx NY, Jacksonville FL, Rochester MN, Houston TX
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT07525141

Phase 1, Recruiting

Improving Outcomes in Early Menopause After Cancer

for
Early Menopause, Cancer, Premature Menopause,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18 - 44

Code: NCT06982677

Recruiting

Video Inspired Discussions About Ethical Outcomes in Pediatrics

for
Pediatric Cancer
Location: Boston MA, Atlanta GA, Birmingham AL
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0+

Code: NCT06786104

Recruiting

Study of FID-022 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Tampa FL, Duarte CA, Los Angeles CA
Sponsor: Fulgent Pharma LLC.

Sex: All

Age: 18+

Code: NCT06694480

Phase 1, Recruiting

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

for
Medulloblastoma, Central Nervous System Embryonal Tumor,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 1 - 30

Code: NCT07087002

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial